In this interview, industry experts Mathieu Bennet and Dustin Whitson explore how automation and single-cell technologies are transforming high-throughput B-cell cloning for antibody discovery. Can ...

Proprietary discovery platform, stemECHO, clones and characterizes the role of epithelial stem cells in the pathogenesis of inflammation and cancer, identifying druggable targets for the treatment and ...

Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...

This variant can protect against a type of cell cloning in the blood, the study found. Farmers learn exact aid amounts from ...